Search
for
Sort by
Research 91–120 of 1000+
- The Many Faces of Calcineurin Inhibitor Toxicity—What the FK?
- The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System
- Low-Dose Oral Minoxidil During Chemotherapy: A Review of the Mechanism and Current Evidence
- The green healer: an updated review on the phytochemical profile and therapeutic potential of Aloe vera
- Natural Remedies for Hypercholesteremia
- Sex hormones and sarcopenia in older persons
- Let astaxanthin be thy medicine
- Forum
- Direct Vasodilators and Sympatholytic Agents
- Characterization of Soluplus/ASC-DP Nanoparticles Encapsulated with Minoxidil for Skin Targeting
- The Requirement to Monitor Low-dose Oral Minoxidil in the Management of Hair Loss
- NEW FORMULATIONS: Glatiramer acetate
- Topical minoxidil therapy for hair regrowth.
- Pharmacodynamic Evaluation: Endocrinology
- K channel therapeutics at the bedside
- Unexpected coronary vasospasm: a case of systemic minoxidil-induced angina pectoris
- Pharmacological management of polycystic ovary syndrome
- Farmácia Lemos, Porto e Serviços Farmacêuticos da Unidade Local de Saúde de Matosinhos, EPE (Hospital Pedro Hispano), Senhora da Hora
- Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
- Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014)
- Medikamentöse Therapie des benignen Prostatasyndroms mit α1-Rezeptorblockern Grundlagen und klinische Ergebnisse
- Erectile Dysfunction in Young Men—A Review of the Prevalence and Risk Factors
- New approaches to the treatment of osteoporosis
- Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Complementary Therapy with Traditional Chinese Medicine for Polycystic Ovarian Syndrome
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Targeted Nanoparticle Delivery for Vascular Regeneration and Ischemia-Reperfusion Injury through Multi-Objective Formulation Optimization